Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02202109 · ClinicalTrials.gov registry record · NA

Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida

A NA study of Cervical Cancer, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
602
Enrollment target
1
Study location

NCT02202109 is a NA study of Cervical Cancer that has completed, run by University of Miami. The registered enrollment target is 602 participants, roughly in line with the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02202109, a NA study of Cervical Cancer, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
602 participants
Enrollment target
1
Study location

Study Summary

The study will test the significance of community health worker (CHW) participation by comparing self-sampling provided by a community health worker and self-sampling provided by mail. The study will enroll 700 participants in communities that lack access to medical care in South Florida.

Conditions Studied

Interventions

  • BEHAVIORAL CHW and Self-sampling for Cervical Cancer
  • BEHAVIORAL Mailed Self Sampler

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 602 participants
Start Date 2015-01
Est. Completion 2017-08
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT02202109

The ClinicalTrials.gov registry entry for NCT02202109 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 602 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 2 interventions - of which CHW and Self-sampling for Cervical Cancer is the first listed.

NCT02202109 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02202109 about?

NCT02202109 is a clinical study titled "Using CHWs or Mailing Self Sampling Home Tests to Increase Cervical Cancer Screening in South Florida". The study will test the significance of community health worker (CHW) participation by comparing self-sampling provided by a community health worker and self-sampling provided by mail. The study will enroll 700 participants in communities that lack access to medical care in South Florida.

What is the current status of trial NCT02202109?

This trial is currently completed. It is a NA study. The enrollment target is 602 participants. The study started on 2015-01. Estimated completion is 2017-08.

What conditions does trial NCT02202109 study?

This clinical trial studies the following conditions: Cervical Cancer.

What interventions are being tested in trial NCT02202109?

The interventions under investigation include: CHW and Self-sampling for Cervical Cancer (BEHAVIORAL), Mailed Self Sampler (BEHAVIORAL).

Who is sponsoring clinical trial NCT02202109?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02202109 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cervical Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.